In another big win for pharmacy this year, on June 14, 2019, Texas Governor Greg Abbott signed into law Senate Bill 1056 by State Sen. Judith Zaffirini and State Rep. John Raney, which clarifies collaborative practice between pharmacists and physicians. Specifically, the legislation amends the Occupations Code and clarifies that a physician may delegate to any properly qualified and trained pharmacist the implementation and modification of a patient’s drug therapy under protocol.
What does this mean for pharmacists?
Pharmacists, particularly those practicing in a community or long-term care setting, can now be part of team-based care through collaborative practice. All pharmacists may now enter into collaborative practice agreements with physicians for their patients and establish protocols for a patient’s drug therapy regimen.
Effective Date: Not later than December 1, 2019, the Texas State Board of Pharmacy shall adopt rules to implement.
TPA's online legislative wrapup offers a full list of which bills passed, which bills failed, and which bills TPA helped to defeat. It also provides effective dates and a detailed explanation of what the legislation means for pharmacy.
This press release GROSSLY misrepresents what the legislation accomplished. Pharmacists in the settings listed have had authority to monitor and adjust therapy under collaborative practice agreements/protocols before this legislation. The legislation does not broaden the ability for pharmacists and physicians outside of these settings to enter into CPAs. Very disappointing TPA. This is not really a win for pharmacy.
Email to a Friend
